US0367521038 - Common Stock
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.
ELV earnings call for the period ending March 31, 2024.
ELV stock results show that Elevance Health beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Elevance Health Inc. raised its outlook for the year on first-quarter results that offered some relief to investors after a cyberattack against a rival roiled the health-insurance sector.
Final Medicare Advantage rates were unchanged vs. the initial proposal.
Major health insurers will now cover Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy for certain Medicare beneficiaries with heart-related conditions.